Suchergebnisse - "Rybicki, Lisa"

PubPharm (12)

1

Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes

enthalten in: Journal of gastrointestinal cancer | 2017

von McNamara, M. | Adelstein, D. | Allende, D. | +10

2

A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2014

von McNamara, M. | Adelstein, D. | Bodmann, J. | +11

3

Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck

enthalten in: Head & neck | 2012

von Rodriguez, C. | Adelstein, D. | Rybicki, L. | +5

4

Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly

enthalten in: Head & neck | 2012

von Michal, S. | Adelstein, D. | Rybicki, L. | +5

5

A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2010

von Rodriguez, C. | Adelstein, D. | Rice, T. | +6

6

Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2009

von Adelstein, D. | Rice, T. | Rybicki, L. | +6

7

Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy

enthalten in: Head & neck | 2008

von Rodriguez, C. | Adelstein, D. | Rybicki, L. | +7

8

A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction : the impact of clinical heterogeneity

enthalten in: American journal of clinical oncology | 2007

von Adelstein, D. | Rice, T. | Rybicki, L. | +7

9

Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer : mature results from a single institution

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2006

von Adelstein, D. | Saxton, J. | Rybicki, L. | +6

CommentIn: J Clin Oncol. 2006 Mar 1;24(7):1023-5. - PMID 16505419

10

Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer

enthalten in: Chest | 2005

von Abou-Jawde, R. | Mekhail, T. | Adelstein, D. | +4